A new injectable “biogel” is effective in delivering anti-cancer agents directly into cancerous tumours and killing them. This technology, developed by researchers at the University of Montreal Hospital Research Centre (CRCHUM), has already been successfully tested in the laboratory. If it works in patients, the therapy could one day revolutionize treatment for many forms of cancer.
Unlike “jello,” the biogel is liquid at room temperature and gels at 37 degrees Celsius – human body temperature. “The strength of this biogel is that it is compatible with anti-cancer immune cells. It is used to encapsulate these cells and eventually administer them using a syringe or catheter into the tumour or directly beside it. Instead of injecting these cells or anti-cancer drugs throughout the entire body via the bloodstream, we can treat the cancer locally. We hope that this targeted approach will improve current immunotherapies,” said Réjean Lapointe, co-author of a study on the technology that was recently published in Biomaterials.
One form of immunotherapy involves treating cancer patients with anti-cancer immune cells. This is called adoptive cell therapy. These cells (T lymphocytes or T cells) are produced naturally by the body and have the ability to destroy cancer cells, but they are generally too weak and too few to eradicate the cancer alone. T cells are therefore cultivated in the laboratory – often the patient’s own cells – and then reinjected into the patient’s blood. While this form of immunotherapy has shown promising results in cases of advanced cancer, it is not always possible to generate enough T cells. Moreover, high doses of interleukin-2, a hormone added to maximize the therapy have a toxic effect. “With our technique, we only need to administer a few dozen million T cells, instead of the billions currently required. We can also administer compounds that ‘awaken’ the immune system to fight against cancer,” explained Lapointe, who is a researcher at the CRCHUM and professor at the University of Montreal.
The recipe for this promising biogel was developed by Sophie Lerouge, a researcher at the CRCHUM and professor in the Department of Mechanical Engineering at the École de technologie supérieure. “The compound is made from chitosane, a biodegradable material extracted from the shells of crustaceans, to which gelling agents are added. “The formulation is liquid at room temperature, which facilitates its injection, but quickly takes on a cohesive and resistant structure at 37 degrees. We also needed a hydrogel that was non-toxic for the body and provided excellent survival and growth of the encapsulated cells,” said the engineer. A real challenge for Lerouge’s team, who tested several formulations before arriving at this “intelligent” biogel.
The biogel was successfully tested in several in vitro models, including melanoma and kidney cancer. “The T lymphocytes in the gel are functional and can grow for two to three weeks, be released from the gel, and kill the cancerous cells,” explained Lapointe. The next step is to demonstrate the effectiveness of the biogel in animals and humans. If the trials are successful, this new approach could be added to current cancer therapies in a few years.
Read more: Intelligent gel attacks cancer
The Latest on: Intelligent biogel
via Google News
The Latest on: Intelligent biogel
- Spacer length dependence on the efficiency of dimeric anionic peptides in gene transfer by glycosylated polylysine/plasmid complexes on March 1, 2019 at 3:45 am
Amphiphilic anionic peptides have been used to enhance the efficiency of transfection by helping plasmids to escape from endosomes to the cytosol. It has been shown that efficiency of an eicosamers co... […]
- New intelligent gel directly attacks cancer on January 20, 2019 at 4:00 pm
Toronto, Nov 20 (IANS) In a new breakthrough in cancer treatment, University of Montreal Hospital Research Centre (CRCHUM) researchers have developed an injectable 'biogel' that can effectively delive... […]
- Injectable, intelligent gel targets cancer at the source on July 31, 2016 at 8:15 pm
Researchers may now have discovered a more efficient way forward, with the development of a T cell-loaded biogel that can be injected directly into the tumor for a more targeted, less laborious approa... […]
- New intelligent gel directly attacks cancer on June 7, 2016 at 1:00 am
In a new break-through in cancer treatment, the researchers in the University of Montreal Centre (CRCHUM) have developed an injectable “Biogel” that can effectively deliver anti-cancer agents directly ... […]
- New intelligent gel directly attacks cancer on November 20, 2015 at 2:15 am
In a new breakthrough in cancer treatment, University of Montreal Hospital Research Centre (CRCHUM) researchers have developed an injectable 'biogel' that can effectively deliver anti-cancer agents di... […]
- Intelligent gel attacks cancer on November 19, 2015 at 9:44 am
A real challenge for Lerouge's team, who tested several formulations before arriving at this "intelligent" biogel. The biogel was successfully tested in several in vitro models, including melanoma and ... […]
- Study of magnetic responsive biopolymer based materials on September 29, 2011 at 5:00 pm
The aim of the proposed project is to synthesize and characterize new nanostructured magneto-responsive biopolymer-based materials by the introduction of functionalized magnetic nanoparticles in bioge... […]
- Biogel Surgical Gloves Global Business Unit is in U.S. on August 29, 2007 at 5:00 pm
NORCROSS, Ga., Aug. 24 / -- Molnlycke Health Care announces that global headquarters for its Biogel® surgical gloves business unit is now in the United States, according to Bob Contreras, president, G... […]
- Sterile Exam Gloves feature powder-free, non-latex design. on March 22, 2007 at 5:00 pm
New Glove - BioExam(TM) - is a powder-free, nitrile non-latex glove NORCROSS, Ga., March 12 /-- Molnlycke Health Care US, LLC, maker of Biogel(R) surgical gloves and the only major medical glove compa... […]
via Bing News